Accordingly, in comparison with other combinations, the combination of high-level H2AFJ and HDAC3 expressions was significantly (p < 0.01) associated with a shorter overall survival time of GBM patients (Figure 6F). This evidence concerns the gene HDAC3 and glioblastoma.